-
-
-
-
-
-
-
NeuroRx and Georgian Ministry of Health Agree to Initiate Expanded Access Program of ZYESAMI (aviptadil acetate) for COVID-19 Respiratory Failure in Georgia
-
-
-
-
-
-
-
NeuroRx Announces ZYESAMIâ„¢ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19
-
-
-
-
-
-
-
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration
-
-
-
-
-
-
-
Form 425 Big Rock Partners Acquis Filed by: Big Rock Partners Acquisition Corp.
-
-
-
-
-
-
-
Big Rock Partners Acquisition Corp. Announces Extension of Time to Consummate Business Combination
-
-
-
-
921,783 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All